Search

Shibnath M Ghatak

from Summerville, SC
Age ~76

Shibnath Ghatak Phones & Addresses

  • Summerville, SC
  • 7 Lanes End, Natick, MA 01760 (508) 652-9038
  • 3226 Sand Marsh Ln, Mt Pleasant, SC 29466 (843) 849-9055
  • Mount Pleasant, SC
  • 6 Pearl St, Medford, MA 02155 (781) 396-0976
  • Boston, MA

Work

Position: Professional/Technical

Education

Degree: Associate degree or higher

Publications

Us Patents

Methods And Compositions For Inhibition Of Multi-Drug Resistance By Hyaluronan Oligomers

View page
US Patent:
20040229843, Nov 18, 2004
Filed:
Apr 29, 2004
Appl. No.:
10/835511
Inventors:
Bryan Toole - Mt. Pleasant SC, US
Suniti Misra - Mount Pleasant SC, US
Shibnath Ghatak - Mount Pleasant SC, US
International Classification:
A61K031/728
US Classification:
514/054000
Abstract:
Pharmaceutical compositions and methods for sensitizing multi-drug resistant cancer or radiation resistant cancer cells to chemotherapeutic agents are provided. Compositions include ligands of hyaluronan receptors, including glycosaminoglycans such as hyaluronan oligomers and derivatives of these oligomers, hyaluronan binding proteins, antibodies specific for hyaluronan receptors, hyaluronan mimetics, inhibitors of hyaluronan synthesis, and stimulators of hyaluronan degradation.

Methods And Compositions For Inhibition Of Multi-Drug Resistance By Hyaluronan Oligomers

View page
US Patent:
20120095277, Apr 19, 2012
Filed:
Dec 28, 2011
Appl. No.:
13/338809
Inventors:
Bryan P. Toole - Mt. Pleasant SC, US
Suniti Misra - Mt. Pleasant SC, US
Shibnath Ghatak - Mt. Pleasant SC, US
Assignee:
TRUSTEES OF TUFTS COLLEGE - Boston MA
International Classification:
A61N 5/00
A61K 31/728
A61K 38/13
A61P 35/00
A61K 31/7088
A61K 39/395
A61P 31/04
C08B 37/08
C07K 16/00
US Classification:
600 1, 536 53, 514 54, 514 205, 514 34, 5303871, 514 44 A, 4241721
Abstract:
Pharmaceutical compositions and methods for sensitizing multi-drug resistant cancer or radiation resistant cancer cells to chemotherapeutic agents are provided. Compositions include ligands of hyaluronan receptors, including glycosaminoglycans such as hyaluronan oligomers and derivatives of these oligomers, hyaluronan binding proteins, antibodies specific for hyaluronan receptors, hyaluronan mimetics, inhibitors of hyaluronan synthesis, and stimulators of hyaluronan degradation.
Shibnath M Ghatak from Summerville, SC, age ~76 Get Report